GOVX (Geovax Labs) Other Current Receivables : $0.66 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Geovax Labs Other Current Receivables?

Geovax Labs's Other Current Receivables for the quarter that ended in Dec. 2024 was $0.66 Mil.

Geovax Labs's quarterly Other Current Receivables stayed the same from Jun. 2024 ($0.00 Mil) to Sep. 2024 ($0.00 Mil) but then increased from Sep. 2024 ($0.00 Mil) to Dec. 2024 ($0.66 Mil).

Geovax Labs's annual Other Current Receivables stayed the same from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.00 Mil) but then increased from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.66 Mil).

Geovax Labs Other Current Receivables Historical Data

The historical data trend for Geovax Labs's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Geovax Labs Other Current Receivables Chart

Geovax Labs Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Receivables

Get a 7-Day Free Trial

0.18

0.05

0.66

Geovax Labs Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Current Receivables	Get a 7-Day Free Trial															-	-	-	-	0.66

Geovax Labs Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Geovax Labs Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Geovax Labs's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Geovax Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Geovax Labs Inc (NAS:GOVX) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

1900 Lake Park Drive, Suite 380, Smyrna, GA, USA, 30080

Website

https://www.geovax.com

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

Executives

Spencer John N Jr	director	2859 PACES FERRY RD, STE 1000, ATLANTA GA 30339
John W. Sharkey	officer: VP, Business Development	16857 E. SAGUARO BLVD., FOUNTAIN HILLS AZ 85268
David A Dodd	director	C/O SEROLOGICALS CORP, 5565 SPALDING DR, NORCROSS GA 30092
Mark Reynolds	officer: Chief Financial Officer	TWO BALA PLAZA, SUITE 300, PHILADELPHIA PA 19004
Mckee Kelly T. Jr.	officer: Chief Medical Officer	233 VALLEY MEADOW DRIVE, CHAPEL HILL NC 27516
Jayne Morgan	director	1900 LAKE PARK DRIVE, SUITE 380, SMYRNA GA 30080
Randal D Chase	director	28 GEORGIA COURT, RICHMOND HILL A6 L4E ON7
Nicole Lemerond	director	3 MURRAY HILL ROAD, SCARSDALE NY 10583
Dean G Kollintzas	director	1256 BRIARCLIFF ROAD N.E., EMTECH BIO SUITE 500, ATLANTA GA 30306
Robert T Mcnally	director
Farshad Guirakhoo	officer: Sr VP, Research & Development	39 CHESTNUT STREET, MELROSE MA 02176
Steven S. Antebi	director	10550 FONTENELLE WAY, LOS ANGELES CA 90077
Harriet L Robinson	other: Chair, Scientific Adv Brd	1256 BRIARCLIFF ROAD N.E., EMTECH BIO SUITE 500, ATLANTA GA 30306
Mark J Newman	officer: VP, Research & Development	1900 LAKE PARK DR, SUITE 380, SMYRNA GA 30080
Peter M Tsolinas	director	123 JOAN DRIVE, BARRINGTON IL 60010